A prospective post-marketing survey of the clinical use of pregabalin: A reliable tool to detect rare or late adverse events

被引：0
|
作者：
Pollard, John R. [1 ]
Herman, Susan T. [1 ]
Litt, Brian [1 ]
Krieger, Ruth S. [1 ]
French, Jacqueline A. [1 ]
机构：
[1] Hosp Univ Penn, Dept Neurol, Div Epilepsy, Philadelphia, PA 19104 USA
来源：
EPILEPSIA | 2006年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：170 / 170
页数：1
相关论文
共 8 条
  • [1] Post-Marketing Survey of Adverse Events Following Ocriplasmin
    Shah, Sumit P.
    Jeng-Miller, Karen W.
    Fine, Howard F.
    Wheatley, H. Matthew
    Roth, Daniel B.
    Prenner, Jonathan L.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2016, 47 (02): : 156 - 160
  • [2] Determining sample size for post-marketing surveillance of rare adverse events
    Wang, Jianmin
    Sherrill, Beth
    Irish, William
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S119 - S120
  • [3] PREGABALIN USE IN EPILEPSY: RESULTS OF THE POST-MARKETING ANTIEPILEPTIC DRUG/DEVICE SURVEY (PADS)
    Morris, G. L.
    Swartz, B.
    Tatum, W. O.
    Burgerman, R.
    Fountain, N. B.
    Montouris, G. D.
    French, J. A.
    Faught, R. E., Jr.
    Harden, C.
    Brown, L.
    Bourgeois, B.
    Kanner, A.
    Kroll, Jennifer L.
    [J]. EPILEPSIA, 2009, 50 : 123 - 124
  • [4] PREDICTORS OF ADVERSE EVENTS FOLLOWING X-TACK USE: A CASE CONTROL ANALYSIS OF A POST-MARKETING REGISTRY
    Sayegh, Lea
    Salameh, Yara
    Buttar, Navtej
    Song, Louis Wong Kee
    Chandrasekhara, Vinay
    Abu Dayyeh, Barham
    Storm, Andrew
    [J]. GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB746 - AB747
  • [5] A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort
    Outteryck, O.
    Ongagna, J. C.
    Brochet, B.
    Rumbach, L.
    Lebrun-Frenay, C.
    Debouverie, M.
    Zephir, H.
    Ouallet, J. C.
    Berger, E.
    Cohen, M.
    Pittion, S.
    Laplaud, D.
    Wiertlewski, S.
    Cabre, P.
    Pelletier, J.
    Rico, A.
    Defer, G.
    Derache, N.
    Camu, W.
    Thouvenot, E.
    Moreau, T.
    Fromont, A.
    Tourbah, A.
    Labauge, P.
    Castelnovo, G.
    Clavelou, P.
    Casez, O.
    Hautecoeur, P.
    Papeix, C.
    Lubetzki, C.
    Fontaine, B.
    Couturier, N.
    Bohossian, N.
    Clanet, M.
    Vermersch, P.
    de Seze, J.
    Brassat, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (01) : 40 - 48
  • [6] Post-marketing surveillance: Adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries
    Overbosch, D
    [J]. JOURNAL OF TRAVEL MEDICINE, 2003, 10 : S16 - S20
  • [7] A Comparative Study of Treatment-Emergent Adverse Events Following Use of Common Bowel Preparations Among a Colonoscopy Screening Population: Results from a Post-Marketing Observational Study
    Kathryn Anastassopoulos
    Francis A. Farraye
    Tyler Knight
    Sam Colman
    Mark vB. Cleveland
    Russell W. Pelham
    [J]. Digestive Diseases and Sciences, 2016, 61 : 2993 - 3006
  • [8] A Comparative Study of Treatment-Emergent Adverse Events Following Use of Common Bowel Preparations Among a Colonoscopy Screening Population: Results from a Post-Marketing Observational Study
    Anastassopoulos, Kathryn
    Farraye, Francis A.
    Knight, Tyler
    Colman, Sam
    Cleveland, Mark vB.
    Pelham, Russell W.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (10) : 2993 - 3006
1